ATE450794T1 - Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen - Google Patents

Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen

Info

Publication number: ATE450794T1
Authority: AT; Austria
Prior art keywords: rbc; carbamatene; spherization; carbamate; containing multifunctional
Prior art date: 2000-09-14

Application number

AT01430028T

Other languages

English (en)

Inventor

Agthoven Andre Van

Jean-Pierre Daziano

John Allen Maples

Original Assignee

Immunotech Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-14

Filing date

2001-09-12

Publication date

2009-12-15

2001-09-12 Application filed by Immunotech Sa filed Critical Immunotech Sa

2009-12-15 Application granted granted Critical

2009-12-15 Publication of ATE450794T1 publication Critical patent/ATE450794T1/de

Links

210000003743 erythrocyte Anatomy 0.000 title abstract 7
239000003153 chemical reaction reagent Substances 0.000 title abstract 2
RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 abstract 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
230000009089 cytolysis Effects 0.000 abstract 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
239000003146 anticoagulant agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
239000001569 carbon dioxide Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5002—Partitioning blood components
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Ecology (AREA)
Tropical Medicine & Parasitology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cephalosporin Compounds (AREA)

AT01430028T 2000-09-14 2001-09-12 Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen ATE450794T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0011746A FR2813891B1 (fr)	2000-09-14	2000-09-14	Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications

Publications (1)

Publication Number	Publication Date
ATE450794T1 true ATE450794T1 (de)	2009-12-15

Family

ID=8854314

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01430028T ATE450794T1 (de)	2000-09-14	2001-09-12	Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen

Country Status (8)

Country	Link
US (2)	US7300797B2 (de)
EP (1)	EP1189061B1 (de)
JP (2)	JP4907022B2 (de)
AT (1)	ATE450794T1 (de)
AU (1)	AU768108B2 (de)
DE (1)	DE60140647D1 (de)
FR (1)	FR2813891B1 (de)
NZ (1)	NZ514161A (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101349644B (zh)	2007-07-20	2012-06-27	深圳迈瑞生物医疗电子股份有限公司	一种白细胞分类试剂和其使用方法
US8102161B2 (en) *	2007-09-25	2012-01-24	Tdk Corporation	Stable output in a switching power supply by smoothing the output of the secondary coil
CN101475754A (zh)	2008-01-04	2009-07-08	深圳迈瑞生物医疗电子股份有限公司	不对称菁类荧光染料,组合物及在生物样品染色中的用途
CN101602762B (zh)	2008-06-10	2013-10-16	深圳迈瑞生物医疗电子股份有限公司	不对称菁类化合物、其制备方法及应用
CN101726579B (zh)	2008-10-17	2014-06-18	深圳迈瑞生物医疗电子股份有限公司	血液检测试剂和方法
US8367358B2 (en)	2008-12-17	2013-02-05	Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	Reagent, kit and method for differentiating and counting leukocytes
CN101988082B (zh)	2009-07-31	2015-04-08	深圳迈瑞生物医疗电子股份有限公司	白细胞分类计数试剂、试剂盒及其制备方法和白细胞分类计数的方法
ES2913337T3 (es) *	2013-11-05	2022-06-01	Hoffmann La Roche	Uso de un reactivo para la lisis de eritrocitos, así como procedimientos y kits relacionados con el mismo
US10577627B2 (en)	2014-06-09	2020-03-03	Voyager Therapeutics, Inc.	Chimeric capsids
EP3215191B1 (de)	2014-11-05	2024-08-14	Voyager Therapeutics, Inc.	Aadc-polynukleotide zur behandlung von morbus parkinson
CN114717264A (zh)	2014-11-14	2022-07-08	沃雅戈治疗公司	治疗肌萎缩性侧索硬化(als)的组合物和方法
KR20230145206A (ko)	2014-11-14	2023-10-17	보이저 테라퓨틱스, 인크.	조절성 폴리뉴클레오티드
US11697825B2 (en)	2014-12-12	2023-07-11	Voyager Therapeutics, Inc.	Compositions and methods for the production of scAAV
US20180230489A1 (en)	2015-10-28	2018-08-16	Voyager Therapeutics, Inc.	Regulatable expression using adeno-associated virus (aav)
EP3371591A4 (de) *	2015-11-02	2018-11-14	Chiranjit Deka	Lichtstreuerbasierte vorrichtung und verfahren zur hämatologieanalyse mit verwendung von nur drei detektoren
JPWO2017141789A1 (ja) *	2016-02-19	2018-12-13	コニカミノルタ株式会社	血液由来検体の保管方法および希少細胞の判定方法
EP3448874A4 (de)	2016-04-29	2020-04-22	Voyager Therapeutics, Inc.	Zusammensetzungen zur behandlung einer erkrankung
EP3448987A4 (de)	2016-04-29	2020-05-27	Voyager Therapeutics, Inc.	Zusammensetzungen zur behandlung einer erkrankung
IL297576B2 (en)	2016-05-18	2024-02-01	Voyager Therapeutics Inc	Compositions and methods of treating huntington's disease
US10584337B2 (en)	2016-05-18	2020-03-10	Voyager Therapeutics, Inc.	Modulatory polynucleotides
EP3831281B1 (de)	2016-08-30	2026-02-25	The Regents of The University of California	Vorrichtungen und systeme für biomedizinische zielführung und verabreichung
MX2019013172A (es)	2017-05-05	2020-09-07	Voyager Therapeutics Inc	Composiciones y metodos para tratar la enfermedad de huntington.
EP3618839A4 (de)	2017-05-05	2021-06-09	Voyager Therapeutics, Inc.	Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
WO2018220835A1 (ja) *	2017-06-02	2018-12-06	日立化成株式会社	血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar)	2017-06-15	2019-11-20	Voyager Therapeutics Inc	بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en)	2017-07-17	2019-01-24	Voyager Therapeutics, Inc.	Trajectory array guide system
US11512327B2 (en)	2017-08-03	2022-11-29	Voyager Therapeutics, Inc.	Compositions and methods for delivery of AAV
MX2020003042A (es)	2017-09-29	2020-11-18	Voyager Therapeutics Inc	Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
TW202413649A (zh)	2017-10-16	2024-04-01	美商航海家醫療公司	肌萎縮性脊髓側索硬化症(als)之治療
WO2019079242A1 (en)	2017-10-16	2019-04-25	Voyager Therapeutics, Inc.	TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
EP3762500A1 (de)	2018-03-06	2021-01-13	Voyager Therapeutics, Inc.	Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
CN112424359A (zh)	2018-05-15	2021-02-26	沃雅戈治疗公司	用于治疗帕金森氏病的组合物和方法
US20210207167A1 (en)	2018-05-16	2021-07-08	Voyager Therapeutics, Inc.	Aav serotypes for brain specific payload delivery
WO2019222444A2 (en)	2018-05-16	2019-11-21	Voyager Therapeutics, Inc.	Directed evolution
US20210254103A1 (en)	2018-07-02	2021-08-19	Voyager Therapeutics, Inc.	Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
WO2020023612A1 (en)	2018-07-24	2020-01-30	Voyager Therapeutics, Inc.	Systems and methods for producing gene therapy formulations
US12281321B2 (en)	2018-09-28	2025-04-22	Voyager Therapeutics, Inc.	Frataxin expression constructs having engineered promoters and methods of use thereof
WO2020072849A1 (en)	2018-10-04	2020-04-09	Voyager Therapeutics, Inc.	Methods for measuring the titer and potency of viral vector particles
CA3125770A1 (en)	2019-01-18	2020-07-23	Voyager Therapeutics, Inc.	Methods and systems for producing aav particles
US20220243225A1 (en)	2019-04-29	2022-08-04	Voyager Therapeutics, Inc.	SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
EP4010465A1 (de)	2019-08-09	2022-06-15	Voyager Therapeutics, Inc.	Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
EP4022070A1 (de)	2019-08-26	2022-07-06	Voyager Therapeutics, Inc.	Kontrollierte expression viraler proteine
EP4192514A1 (de)	2020-08-06	2023-06-14	Voyager Therapeutics, Inc.	Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
WO2022187473A2 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
WO2022187548A1 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
WO2024054983A1 (en)	2022-09-08	2024-03-14	Voyager Therapeutics, Inc.	Controlled expression of viral proteins

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1072884B (de) *	1957-06-14	1960-01-07	Dr. Ulrich Schmiedel Hamburg-Othmarschen, und TECHNOPHOT Dr. Rudolf Fischer K.G., Berlin-Neukölln	Verfahren zur Entwicklung, Übertragung und Fixierung elektrophotographischer Bilder
JPS5446810A (en) *	1977-09-20	1979-04-13	Asahi Chem Ind Co Ltd	Hemolyzation of erythrocyte
US4710573A (en) *	1983-08-22	1987-12-01	Hoechst Roussel Pharmaceuticals, Inc.	3-(piperidinyl)-and 3-(pyrrolidinyl)-1H-indazoles
US5389549A (en) *	1987-05-29	1995-02-14	Toa Medical Electronics Co., Ltd.	Method for classifying leukocytes and a reagent used therefor
JP2619900B2 (ja) *	1988-01-27	1997-06-11	東亜医用電子株式会社	血液中の白血球およびヘモグロビンの測定用試薬および方法
EP0538314B1 (de) *	1990-07-12	1997-06-18	Pfizer Inc.	Carbamate des indan-pyrrolidins
TW200462B (de) *	1990-09-27	1993-02-21	Hoechst Roussel Pharma
EP0685994B1 (de) *	1993-02-25	2007-03-21	Abbott Laboratories	Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
FR2705360B1 (fr) *	1993-05-19	1995-08-18	Immunotech Sa	Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
US5721236A (en) *	1993-10-15	1998-02-24	Schering Corporation	Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5432054A (en) *	1994-01-31	1995-07-11	Applied Imaging	Method for separating rare cells from a population of cells
US5716776A (en) *	1994-03-04	1998-02-10	Mark H. Bogart	Enrichment by preferential mitosis of fetal lymphocytes from a maternal blood sample
US5569410A (en) *	1994-11-17	1996-10-29	Elf Atochem North America, Inc.	Ammonium bicarbonate/ammonium carbamate activated benzyl alcohol paint stripper
US5559037A (en) *	1994-12-15	1996-09-24	Abbott Laboratories	Method for rapid and simultaneous analysis of nucleated red blood cells
DE69624908T2 (de) *	1995-03-08	2003-07-03	Bioseparations, Inc.	Methode zur erreicherung von populationen seltener zellen
US5882933A (en) *	1995-06-08	1999-03-16	Coulter International Corp.	Method for determination of leukocytes and hemoglobin concentration in blood
US5686308A (en) *	1995-06-08	1997-11-11	Coulter Corporation	Reagent and method for differential determination of leukocytes in blood
US5843608A (en) *	1995-06-08	1998-12-01	Coulter International Corp.	Reagent and method for differential determination of leukocytes in blood
JP2001506005A (ja) *	1996-12-11	2001-05-08	ナイコメッド・アマーシャム・ピーエルシー	細胞の選択的溶解
US6489300B1 (en) *	1997-07-31	2002-12-03	Eugene D. Thorsett	Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
US5917584A (en) *	1997-11-21	1999-06-29	Coulter International Corp.	Method for differentiation of nucleated red blood cells
FR2778413B1 (fr) *	1998-05-07	2000-08-04	Immunotech Sa	Nouveaux reactifs et methode de lyse des erythrocytes
CA2336806A1 (en) *	1998-07-10	2000-01-20	Keith Russell	N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
US6573102B2 (en) *	2001-07-27	2003-06-03	Coulter International Corp.	Lytic reagent composition for determination of nucleated blood cells

2000
- 2000-09-14 FR FR0011746A patent/FR2813891B1/fr not_active Expired - Lifetime
2001
- 2001-09-12 DE DE60140647T patent/DE60140647D1/de not_active Expired - Lifetime
- 2001-09-12 EP EP01430028A patent/EP1189061B1/de not_active Expired - Lifetime
- 2001-09-12 AT AT01430028T patent/ATE450794T1/de not_active IP Right Cessation
- 2001-09-13 NZ NZ514161A patent/NZ514161A/en unknown
- 2001-09-13 AU AU72044/01A patent/AU768108B2/en not_active Expired
- 2001-09-14 JP JP2001279304A patent/JP4907022B2/ja not_active Expired - Lifetime
- 2001-09-14 US US09/951,903 patent/US7300797B2/en not_active Expired - Lifetime
2007
- 2007-10-08 US US11/868,580 patent/US7678583B2/en not_active Expired - Fee Related
2011
- 2011-06-09 JP JP2011129354A patent/JP5187983B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60140647D1 (de)	2010-01-14
EP1189061A1 (de)	2002-03-20
FR2813891A1 (fr)	2002-03-15
EP1189061B1 (de)	2009-12-02
JP5187983B2 (ja)	2013-04-24
AU7204401A (en)	2002-03-28
US7300797B2 (en)	2007-11-27
US20080026475A1 (en)	2008-01-31
AU768108B2 (en)	2003-12-04
US7678583B2 (en)	2010-03-16
JP2011174947A (ja)	2011-09-08
FR2813891B1 (fr)	2005-01-14
JP4907022B2 (ja)	2012-03-28
JP2002148255A (ja)	2002-05-22
NZ514161A (en)	2003-05-30
US20020115118A1 (en)	2002-08-22

Legal Events

Date	Code	Title	Description
2010-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60140647D1 (de)	2010-01-14	Carbamatenthaltendes Multifunktionelles Erythrozytenreagenz und Verwendungen
DE69906859D1 (de)	2003-05-22	Neue Reagenzien und Methoden zur Lyse von Erythrozyten
Visalberghi et al.	1996	Acting and understanding: Tool use revisited through the minds of capuchin monkeys.
IT1137557B (it)	1986-09-10	Procedimento per l'incenerimento contenenti,in bassa concentrazione,almeno un composto dello zolfo scelto tra cos. cs2 ed i mercaptani ed,eventualmente,almeno un membro scelto dal gruppo formato da h2s,so2,zolfo vapore e/o vescicolare
DK0545314T3 (da)	1998-09-07	Reagenssammensætninger og deres anvendelse ved identificeringen og karakteriseringen af reticulocytter i helblod.
ATE360363T1 (de)	2007-05-15	Verfahren und anordnung von beuteln zur konzentrierung weisser zellen
ATE91431T1 (de)	1993-07-15	Entschwefelung.
EP0562877A3 (en)	1993-12-29	Cell fixative and method of staining cells without destroying the cell surface
NO930294D0 (no)	1993-01-28	Stabil fibrinogenopploesning
DK0509281T3 (da)	1997-01-06	Beholderaflukning med gennemstikkeligt aflukningslegeme
ATE107645T1 (de)	1994-07-15	Durch eine heterocyclische gruppe substituierte phenoxyalkylisoxazole und ihre verwendung als antivirale mittel.
NO971173L (no)	1997-03-13	Konserveringsmiddel
EP0033401A3 (en)	1981-08-26	Process for the removal of h2s, co2, cos and mercaptans from gases by absorption, and absorption solution for carrying out the process
ATE74765T1 (de)	1992-05-15	Eine enzymzusammensetzung als verdauungsbeschleuniger bei verschiedenen spiegeln im verdauungskanal und deren herstellungsverfahren.
DE69029291D1 (de)	1997-01-16	Verwendung von Lithiumsalzen zur Lysis von Erythrozyten und zur Denaturierung von Hämoglobin
HUT49411A (en)	1989-09-28	Immunologic method for detecting herbicides
FR2665085B1 (fr)	1992-11-27	Dispositif de conditionnement de systemes absorbeurs d'oxygene et/ou relargueurs de co2.
ES2154289T3 (es)	2001-04-01	Metodos de proteccion de celulas leucocitarias, composicion protectora, composicion de sangre protegida, y metodo de analisis sanguineo.
DK0570355T3 (da)	1999-08-30	Anvendelse af prothrombin-fragmenter
NO180306C (no)	1997-03-26	Fremgangsmåte for fremstilling av en trombinbindende substans, et DNA-fragment som koder for substansen, en rekombinant vektor omfattende nevnte DNA-fragment samt transformert celle inneholdende nevnte rekombinante vektor
Fitzgerald et al.	1987	Blood lead level of children attending an Urban Child Guidance Clinic.
Menninger	1983	The middle of the journey: Dragons and grails.
Mayer et al.	1989	Intellectual Experience Scale
Catton	1953	Lincoln and the War
NO892608L (no)	1989-12-27	Nitrogenholdige heterocykliske forbindelser med antifungal virkning.